BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Firouzabadi N, Navabzadeh N, Moghimi-Sarani E, Haghnegahdar M. Orexin/Hypocretin Type 2 Receptor (HCRTR2) Gene as a Candidate Gene in Sertraline-Associated Insomnia in Depressed Patients. Neuropsychiatr Dis Treat 2020;16:1121-8. [PMID: 32440126 DOI: 10.2147/NDT.S250141] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Gandotra K, Jaskiw G, Fuller M, Vaidya P, Chiang A, Konicki E, Strohl K. Sertraline as an adjunctive treatment for insomnia comorbid with other mental health disorders. Journal of Affective Disorders Reports 2022;10:100389. [DOI: 10.1016/j.jadr.2022.100389] [Reference Citation Analysis]
2 Guo R, Vaughan DT, Rojo ALA, Huang YH. Sleep-mediated regulation of reward circuits: implications in substance use disorders. Neuropsychopharmacology 2022. [PMID: 35710601 DOI: 10.1038/s41386-022-01356-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Kaplan GB, Lakis GA, Zhoba H. Sleep-Wake and Arousal Dysfunctions in Post-Traumatic Stress Disorder:Role of Orexin Systems. Brain Res Bull 2022:S0361-9230(22)00121-6. [PMID: 35618150 DOI: 10.1016/j.brainresbull.2022.05.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Lin C, Huang T. Orexin/hypocretin and major psychiatric disorders. Advances in Clinical Chemistry 2022. [DOI: 10.1016/bs.acc.2022.03.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]